2005

1. Krszyna K, Stokłosa T. Czynnik indukowany przez hipoksję-1 (HIF-1): Budowa, regulacja ekspresji, funkcja oraz rola w progresji nowotworów. Post Biol Kom. 2005; 32(4): 707-728

2. Nowis D, Stokłosa T, Legat M, Issat T, Jakóbisiak M, Gołąb J. The influence of PDT on the immune response. Photodiagn. Photodyn. Ther. 2005 (in press)

3. Ciechomska I, Legat M, Golab J, Wesolowska A, Kurzaj Z, Mackiewicz A, Kaminska B. Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies. Int J Cancer. 2005 Oct 20;117(1):59-67

4. Stoklosa T, Golab J. Prospects for p53-based cancer therapy. Acta Biochim Pol. 2005;52(2):321-8. Epub 2005 Jun 25

5. Nowis D, Makowski M, Stoklosa T, Legat M, Issat T, Golab J. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol. 2005;52(2):339-52

6. Wang J-Y, Ho T, Trojanek J, Chintapalli J, Grabacka M, Stoklosa T, Garcia F-U, Skorski T, Reiss K. Impaired homologous recombination DNA repair and enhanced sensitivity to DNA damage in prostate cancer cells exposed to anchorage-independence. Oncogene 2005 May 26;24(23):3748-58

7. Adamek M, Krawczyk-Krupka A, Mostowy A, Czuba Z, Król W, Kasperczyk S, Jakóbisiak M, Gołąb J, Sieroń A. Topical ALA-PDT modifies neutrophils' chemiluminescence, lymphocytes' interleukin-1 beta secretion and serum level of transforming growth factor beta 1 in patients with non melanoma skin malignancies. A clinical study. Photodiagn. Photodyn. Ther. 2005 (in press)

8. Gołąb J, Stokłosa T, Technology evaluation: SB-485232. Curr. Opin. Mol. Ther. 2005; 7(1):85-93